Last reviewed · How we verify
NCT06797349: GLIN4
Glin4: Assessment of the Glycemic Responses to Nutritional Products
Phase 4 trial testing First Reference product in Glycemic Response in 12 participants. Completed in 4 March 2025.
4 March 2025
Quick facts
| Lead sponsor | Nutricia Research |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 12 |
| Start date | 23 January 2025 |
| Primary completion | 4 March 2025 |
| Estimated completion | 4 March 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- First Reference product
- Second reference product
- Third reference product
- First Concept product
- Second Concept product
- Third Concept product
- Fourth Concept product
- Fifth Concept product
- Sixth Concept product
- Seventh Concept product
Conditions studied
- Glycemic Response — all drugs for Glycemic Response →
Sponsor
Nutricia Research — full company profile →
Who can join
Adults 18 to 65, any sex, with Glycemic Response. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study assesses the glycemic responses to nutritional products. During a study visit fasted subjects will consume one serving of the reference product or the test product. Capillary blood samples will be taken at baseline and at several time-points over a 2-hr period. Several nutritional products will be tested over time.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06797349
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of First Reference product
Trials testing the same drug.
- NCT05308147 — Assessment of the Glycemic Responses to Nutritional Products (v2.0) · NA · unknown
Other recruiting trials for Glycemic Response
Currently open trials in the same condition.
- NCT04881019 — PRediction Of Glycemic RESponse Study · active not recruiting
Other Nutricia Research trials
Trials by the same sponsor.
- NCT07243743 — Assessment of the Glycemic Responses to Nutritional Products-INQ-2526 · NA · completed
- NCT06920550 — A Growth Artificial Intelligence Algorithm for leNgth and Weight Study · recruiting
- NCT06628024 — Determination of the Postprandial Amino Acid Uptake Kinetics of Yoghurt Vs Milk. · NA · completed
- NCT05731206 — Hypoallergenicity of a Hydrolyzed Protein Infant Formula · NA · suspended
- NCT06475521 — A Randomised, Controlled, Double-blinded, Multi-country, Multi-centre Trial to Study Growth and Health Outcomes of a New · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06797349 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nutricia Research
- Last refreshed: 23 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06797349.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing